Optimization of chronic lymphocytic leukemia treatment using game theory
The current strategy of chronic lymphocytic leukemia (CLL) treatment is based on genetic risk factors such as del(17p), TP53 mutations and/or unmutated variant of IGHV genes. Guidelines recommend the usage of targeted drugs, e.g. ibrutinib, in the first line for patients with unfavorable risk factor...
Saved in:
Main Authors: | A. S. Luchinin (Author), V. V. Strugov (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic Lymphocytic Leukemia
Published: (2012) -
Chronic lymphocytic leukemia prediction using data mining methods
by: M. V. Markovtseva, et al.
Published: (2022) -
Individual features of the pharmacokinetics of fludarabin phosphate in the treatment of patients with chronic lymphocytic leukemia
by: G. G. Rodionov, et al.
Published: (2021) -
Immunogenetics of chronic lymphocytic leukemia
by: Nikhil Patkar, et al.
Published: (2017) -
Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013)